Panel 2: Useful Links for Physicians Regarding COVID-19

A.  The following links would help rheumatologists understand the recent perspectives on COVID-19

• Taylor & Francis
• Elsevier
• Wiley
• Springer Nature
• Oxford Univ. Press
• The BMJ
• New England Journal of Medicine
• The Lancet

B.  The following links are from national or international organization to help rheumatologists and patients to manage their diseases during COVID-19

• European League Against Rheumatism (EULAR) guidance for patients on COVID 19
• American College of Rheumatology (ACR)
• World Health Organization
• German Society for Rheumatology – Patient section. (German only) 
• British Society for Rheumatology guidance for rheumatologist
• Shielding policy in UK
• National Rheumatoid Arthritis Society. Coronavirus: What we know so far
• Medical Council of India – Telemedicine Practice Guideline

C.  Management of patients with COVID-19

• World Health Organization (WHO) clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected
• National Institute of Health treatment guideline
• US Food and Drug Administration (FDA) cautions against the use of antimalarial agents outside hospital setting or clinical trial
• Treatment recommendation for Chinese COVID-19 patients
• The Australasian society of clinical immunology an allergy (ASCIA) positional statement

D.  Research on DMARDs related to COVID-19

• Clinicaltrial.gov
• Hydroxychloroquine as postexposure prophylaxis
• Hydroxychloroquine for the Treatment of Patients With Mild to Moderate COVID-19 to Prevent Progression to Severe Infection or Death
• Tocilizumab
• Sarilumab
• Baricitinib

E.  Rheumatology patient registry

• The COVID-19 Global Rheumatology Alliance
• EULAR